Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial.

BACKGROUND Poor quality of information transfer about the benefits and risks of statin drug use may result in patients not making informed decisions that they can act on in a timely fashion. METHODS The effect of a decision aid about statin drugs on treatment decision making in 98 patients with diabetes was determined in a cluster randomized trial of decision aid vs control pamphlet, with concealed allocation, blinding of participants to study goals, and adherence to the intention-to-treat principle. Twenty-one endocrinologists conducted specialty outpatient metabolic consultations. Patients in the intervention group received Statin Choice, a tailored decision aid that presents the estimated 10-year cardiovascular risk, the absolute risk reduction with use of statin drugs, and the disadvantages of using statin drugs. Patients in the control group received the institution's pamphlet about cholesterol management. We measured acceptability, knowledge about options and cardiovascular risk, and decisional conflict immediately after the visit, and adherence to pill taking was measured 3 months later. RESULTS Patients favored using the decision aid (odds ratio [OR], 2.8; 95% confidence interval [CI], 1.2-6.9); patients who received the decision aid (n = 52) knew more (difference, 2.4 of 9 points; 95% CI, 1.5-3.3), had better estimated cardiovascular risk (OR, 22.4; 95% CI, 5.9-85.6) and potential absolute risk reduction with statin drugs (OR, 6.7; 95% CI, 2.2-19.7), and had less decisional conflict (difference, -10.6; 95% CI, -15.4 to -5.9 on a 100-point scale) than did patients in the control group (n = 46). Of 33 patients in the intervention group taking statin drugs at 3 months, 2 reported missing 1 dose or more in the last week compared with 6 of 29 patients in the control group taking statin drugs (OR, 3.4; 95% CI, 1.5-7.5). CONCLUSIONS A decision aid enhanced decision making about statin drugs and may have favorably affected drug adherence.

[1]  João Costa,et al.  Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: metaanalysis of randomised controlled trials , 2006, BMJ : British Medical Journal.

[2]  V. Montori,et al.  A pen-and-paper coronary risk estimator for office use with patients with type 2 diabetes. , 2006, Mayo Clinic proceedings.

[3]  Muhammad Mamdani,et al.  Adherence with statin therapy in elderly patients with and without acute coronary syndromes. , 2002, JAMA.

[4]  David B Lawrence,et al.  Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. , 2005, Diabetes care.

[5]  R. Thomson,et al.  Decision aids for people facing health treatment or screening decisions. , 2003, The Cochrane database of systematic reviews.

[6]  Stacey L. Sheridan,et al.  Heart to Heart: a computerized decision aid for assessment of coronary heart disease risk and the impact of risk-reduction interventions for primary prevention. , 2004, Preventive cardiology.

[7]  Elizabeth Drake,et al.  Development and Preliminary Testing of a Patient Decision Aid to Assist Pharmaceutical Care in the Prevention of Cardiovascular Disease , 2004, Pharmacotherapy.

[8]  R. Haynes,et al.  Is this patient taking the treatment as prescribed , 1993 .

[9]  Stacey L Sheridan,et al.  The impact of a decision aid about heart disease prevention on patients' discussions with their doctor and their plans for prevention: a pilot randomized trial , 2006, BMC Health Services Research.

[10]  M K Campbell,et al.  Cluster trials in implementation research: estimation of intracluster correlation coefficients and sample size. , 2001, Statistics in medicine.

[11]  C. Charles,et al.  Treatment decision aids: conceptual issues and future directions , 2005, Health expectations : an international journal of public participation in health care and health policy.

[12]  R. Haynes,et al.  The rational clinical examination. Is this patient taking the treatment as prescribed? , 1993, JAMA.

[13]  Kevin Weiss,et al.  Lipid Control in the Management of Type 2 Diabetes Mellitus: A Clinical Practice Guideline from the American College of Physicians , 2004, Annals of Internal Medicine.

[14]  A. O'Connor.  Validation of a Decisional Conflict Scale , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[15]  Aileen Clarke,et al.  Developing a quality criteria framework for patient decision aids: online international Delphi consensus process , 2006, BMJ : British Medical Journal.

[16]  V. Montori,et al.  Systematic review of lipid lowering for primary prevention of coronary heart disease in diabetes , 2003, BMJ : British Medical Journal.